-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AFM-24I in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AFM-24I in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AFM-24I in Solid Tumor Drug Details: AFM-24I is under development for...
-
Product Insights
NewQuarterly Milk pricing trends in China
Empower your strategies with our Quarterly Milk pricing trends in China report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important business choices....
-
Product Insights
NewQuarterly Yogurt pricing trends in China
Empower your strategies with our Quarterly Yogurt pricing trends in China report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important business choices....
-
Product Insights
NewQuarterly Carbonates pricing trends in China
Empower your strategies with our Quarterly Carbonates pricing trends in China report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important business choices....
-
Product Insights
NewOrchestra BioMed Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Orchestra BioMed Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Orchestra BioMed Inc (Orchestra BioMed) is a biomedical innovation company focused on developing transformative therapeutic products for large unmet clinical needs in procedure-based medicines. Orchestra BioMed is headquartered in New Hope, Pennsylvania, the US. GlobalData's Medical Devices company profile report, “Orchestra BioMed Inc Pipeline Insight and Competitive Landscape, 2023" provides information about the company overview and analysis on their...
-
Product Insights
NewBaebies Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Baebies Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Baebies Inc (Baebies) helps in saving and making lives better for children with the help of new technology, new hope and new tests to the healthcare professionals and parents worldwide. The company offers seeker, a platform for newborn screening to find lysosomal storage disorders that is authorized by FDA. It also offers FINDER, innovative, small and connected testing solutions designed...
-
Product Insights
NewMuscular Dystrophy – Drugs In Development, 2024
Empower your strategies with our Muscular Dystrophy – Drugs In Development, 2024 report and make more profitable business decisions. Muscular dystrophy is a group of diseases in which muscle fibers are unusually susceptible to damage. These damaged muscles become progressively weaker. Symptoms usually appear before age 6 and may appear as early as infancy. They may include fatigue, learning difficulties, intellectual disability, muscle weakness, and progressive difficulty walking. The Muscular Dystrophy drugs in development market research report provide comprehensive information on...
-
Product Insights
NewEncephalopathy – Drugs In Development, 2024
Empower your strategies with our Encephalopathy – Drugs In Development, 2024 report and make more profitable business decisions. Encephalopathy is a term for any diffuse disease of the brain that alters brain function or structure. Symptoms include seizures, difficulty speaking or swallowing, trembling, involuntary twitching, and muscle weakness. Causes include traumas or injuries, genetics, liver disease, hypoxic condition, Lyme disease, and organ failure. The Encephalopathy drugs in development market research report provide comprehensive information on the therapeutics under development for Encephalopathy,...